Alignment Healthcare, Inc. (ALHC) Stock Price & Analysis
Alignment Healthcare, Inc. (ALHC) fell 2.85% to USD 19.43 as of July 25, 2026 at 03:09 UTC, according to Nexqual real-time market data.
ALHC last closed at USD 20; the session ranged USD 19.34–20.23 on volume of 2,816,741 shares. Market capitalization is $4.02B, with a 52-week range of USD 11.66–25.12 (NMS). Source: Nexqual, July 25, 2026 at 03:09 UTC.
Key Statistics (as of July 25, 2026 at 03:09 UTC)
| Price | USD 19.43 |
|---|---|
| Change | ▼ 2.85% (down) |
| Previous Close | USD 20 |
| Open | USD 20.23 |
| Day Range | USD 19.34 – 20.23 |
| 52-Week Range | USD 11.66 – 25.12 |
| Volume | 2,816,741 shares |
| Market Cap | $4.02B |
| Exchange | NMS |
Technical Analysis (ALHC)
Nexqual's technical model rates ALHC "SELL" based on 2 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 03:09 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.82 (neutral) |
| vs SMA50 | Above (USD 19.34) |
| MACD | -0.03 (negative) |
Analyst Ratings (ALHC)
Wall Street analysts rate ALHC "Strong Buy" based on 13 analysts, with a mean price target of USD 24.92 (range USD 16–30), per Nexqual as of July 25, 2026 at 03:09 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 13 |
| Mean Target | USD 24.92 |
| High Target | USD 30 |
| Low Target | USD 16 |
| Buy / Hold / Sell | 12 / 2 / 0 |
Earnings (ALHC)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 0.2 |
| Revenue Estimate | $1.31B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.12 vs est 0.09 ▲ beat |
| 2025-12-31 | USD -0 vs est -0.08 ▲ beat |
| 2025-09-30 | USD 0.1 vs est -0.01 ▲ beat |
| 2025-06-30 | USD 0.14 vs est 0.01 ▲ beat |
Source: Nexqual, July 25, 2026 at 03:09 UTC.
Financials & Fundamentals (ALHC)
| Total Revenue | $4.26B |
|---|---|
| Revenue Growth (YoY) | +33.30% |
| Gross Margin | +12.38% |
| Operating Margin | +1.29% |
| Profit Margin | +0.46% |
| ROE | +12.53% |
| Debt / Equity | 159.49 |
| Current Ratio | 1.58 |
| Total Cash | $726.29M |
| Total Debt | $329.97M |
| Free Cash Flow | $234.58M |
Source: Nexqual, July 25, 2026 at 03:09 UTC.
Financial Health Score (ALHC)
Nexqual rates Alignment Healthcare, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:09 UTC.
| Growth | Strong — Revenue +46% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 12%, operating 1% |
| Balance Sheet | Weak — $726M cash vs $330M debt, net cash position |
| Cash Flow | Solid — FCF $235M, 6% margin |
| Efficiency | Mixed — ROE 13%, ROA 2.1% |
Ownership (ALHC)
| Insider Ownership | +2.74% |
|---|---|
| Institutional Ownership | +106.96% |
| Shares Outstanding | 206.73M |
| Float | 186.88M |
| Short % of Float | +12.11% |
Source: Nexqual, July 25, 2026 at 03:09 UTC.
Leadership (ALHC)
Alignment Healthcare, Inc. is led by John E. Kao (age 63), Founder, Chairman & CEO, per Nexqual as of July 25, 2026 at 03:09 UTC.
| Founder, Chairman & CEO | John E. Kao (age 63) |
|---|---|
| Vice Chairman & Executive VP of Corporate Affairs | Joseph Samuel Konowiecki (age 71) |
| President | Dawn Christine Maroney (age 57) |
| Chief Financial Officer | James M. Head (age 59) |
Major Backers & Investors (ALHC)
Notable institutional backers of Alignment Healthcare, Inc. include T. Rowe Price, Wellington Management, FMR, LLC, according to Nexqual as of July 25, 2026 at 03:09 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 9.52% |
| Wellington Management | 8.27% |
| FMR, LLC | 7.69% |
| Invesco | 3.39% |
| Hood River Capital Management LLC | 2.93% |
| Price (T.Rowe) Associates Inc | 2.78% |
| Citadel | 2.59% |
| SmallCap World Fund Inc | 2.55% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 16.48% |
| BlackRock | 11.23% |
Source: Nexqual, July 25, 2026 at 03:09 UTC.
From Alignment Healthcare, Inc.'s Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Our internal care teams and external providers use AVA, our proprietary technology platform, to coordinate high-quality care for members and manage the complexity of the healthcare system.
- The US Department of Health and Human Services, Office for Civil Rights ("OCR") announced on December 27, 2024, and published in the Federal Register on January 6, 2025, a Notice of Proposed Rulemaking proposing extensive modifications to the HIPAA security standards.
- In 2026, penalties for violations of HIPAA and its implementing regulations started at $145 per violation and could not exceed approximately $73,011 per violation, subject to a cap of approximately $2.2 million for violations of the same standard in a single calendar year.] However, a single breach incident can result in violations of multiple standards.
- In addition, the HITECH Act mandates that the Secretary of the Department of Health and Human Services ("HHS") conduct periodic compliance audits of HIPAA-regulated covered entities and business associates for compliance with HIPAA's privacy and security standards.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRVA | Privia Health Group, Inc. | USD 25.5 | ▲ 0.51% |
| LFST | LifeStance Health Group, Inc. | USD 10.9 | ▼ 1% |
| AGL | agilon health, inc. | USD 98 | ▼ 18.25% |
| SHC | Sotera Health Company | USD 17.35 | ▲ 0.35% |
| SGRY | Surgery Partners, Inc. | USD 15.73 | ▲ 3.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:09 UTC. This page is informational and not investment advice.